title: Malignant glioma: current treatment perspectives.
abstract: Cytoreduction through multimodality therapy is the primary goal in management of malignant gliomas. Clinical trials such as those offered by the Brain Tumor Cooperative Group help to define current standards of care and investigate new therapies. Available therapies are in the medical, surgical, radiation and chemotherapeutic realms.
authors.forename: B A
authors.initials: BA
authors.lastname: Adams
authors.forename: J K
authors.initials: JK
authors.lastname: Clancey
authors.forename: M
authors.initials: M
authors.lastname: Eddy
mesh_terms: D001918:Brachytherapy / Q000379:methods*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005910:Glioma / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D011879:Radiotherapy Dosage
chemical_list: D007457:Iodine Radioisotopes